$3M Verdict Awarded Against GSK For Failing To Warn Of Suicide In Generic Paxil Case

(April 21, 2017, 12:31 PM EDT) --  CHICAGO — An Illinois federal jury on April 20 awarded $3 million to a widow after finding that GlaxoSmithKline PLC (GSK) failed to update the label for the antidepressant Paxil to warn that the drug can cause suicide in patients older than 24 (Wendy B. Dolin, et al. v. SmithKline Beecham Corporation, et al., No. 12-6403, N.D. Ill., Eastern Div.)....

Related Sections